nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—PPARA—liver cancer	0.448	0.555	CbGaD
Bezafibrate—PPARG—liver cancer	0.214	0.266	CbGaD
Bezafibrate—CYP1A1—liver cancer	0.145	0.179	CbGaD
Bezafibrate—Fenofibrate—PPARA—liver cancer	0.00154	0.243	CrCbGaD
Bezafibrate—Rhabdomyolysis—Sorafenib—liver cancer	0.00146	0.0311	CcSEcCtD
Bezafibrate—Clofibrate—GSTA2—liver cancer	0.00135	0.213	CrCbGaD
Bezafibrate—Clofibrate—PPARA—liver cancer	0.00107	0.169	CrCbGaD
Bezafibrate—Eczema—Sorafenib—liver cancer	0.00104	0.0222	CcSEcCtD
Bezafibrate—Renal failure acute—Sorafenib—liver cancer	0.00101	0.0217	CcSEcCtD
Bezafibrate—Myositis—Epirubicin—liver cancer	0.000971	0.0208	CcSEcCtD
Bezafibrate—Myositis—Doxorubicin—liver cancer	0.000899	0.0192	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.000842	0.018	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.000842	0.018	CcSEcCtD
Bezafibrate—Gastritis—Sorafenib—liver cancer	0.000828	0.0177	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Sorafenib—liver cancer	0.000825	0.0176	CcSEcCtD
Bezafibrate—Transaminases increased—Epirubicin—liver cancer	0.000783	0.0167	CcSEcCtD
Bezafibrate—Serum creatinine increased—Epirubicin—liver cancer	0.000774	0.0165	CcSEcCtD
Bezafibrate—Erectile dysfunction—Sorafenib—liver cancer	0.000745	0.0159	CcSEcCtD
Bezafibrate—Transaminases increased—Doxorubicin—liver cancer	0.000724	0.0155	CcSEcCtD
Bezafibrate—Serum creatinine increased—Doxorubicin—liver cancer	0.000716	0.0153	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000715	0.0153	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Sorafenib—liver cancer	0.000711	0.0152	CcSEcCtD
Bezafibrate—Myocardial infarction—Sorafenib—liver cancer	0.000707	0.0151	CcSEcCtD
Bezafibrate—Urinary tract disorder—Sorafenib—liver cancer	0.000639	0.0137	CcSEcCtD
Bezafibrate—Urethral disorder—Sorafenib—liver cancer	0.000634	0.0136	CcSEcCtD
Bezafibrate—Balsalazide—PPARG—liver cancer	0.000627	0.0991	CrCbGaD
Bezafibrate—Erythema multiforme—Sorafenib—liver cancer	0.000612	0.0131	CcSEcCtD
Bezafibrate—Indomethacin—PPARA—liver cancer	0.000577	0.0912	CrCbGaD
Bezafibrate—Alopecia—Sorafenib—liver cancer	0.000572	0.0122	CcSEcCtD
Bezafibrate—Erythema—Sorafenib—liver cancer	0.000563	0.012	CcSEcCtD
Bezafibrate—Muscle spasms—Sorafenib—liver cancer	0.000542	0.0116	CcSEcCtD
Bezafibrate—Anaemia—Sorafenib—liver cancer	0.000521	0.0111	CcSEcCtD
Bezafibrate—Myalgia—Sorafenib—liver cancer	0.00048	0.0102	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000476	0.0102	CcSEcCtD
Bezafibrate—Infection—Sorafenib—liver cancer	0.000457	0.00976	CcSEcCtD
Bezafibrate—Thrombocytopenia—Sorafenib—liver cancer	0.00045	0.00962	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000441	0.00942	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000419	0.00895	CcSEcCtD
Bezafibrate—Dyspepsia—Sorafenib—liver cancer	0.000405	0.00865	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000398	0.00849	CcSEcCtD
Bezafibrate—Photosensitivity—Epirubicin—liver cancer	0.000394	0.00841	CcSEcCtD
Bezafibrate—Pain—Sorafenib—liver cancer	0.000393	0.0084	CcSEcCtD
Bezafibrate—Constipation—Sorafenib—liver cancer	0.000393	0.0084	CcSEcCtD
Bezafibrate—Vascular purpura—Epirubicin—liver cancer	0.000387	0.00826	CcSEcCtD
Bezafibrate—Eczema—Epirubicin—liver cancer	0.000385	0.00822	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Sorafenib—liver cancer	0.000376	0.00803	CcSEcCtD
Bezafibrate—Renal failure acute—Epirubicin—liver cancer	0.000374	0.008	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000368	0.00786	CcSEcCtD
Bezafibrate—Urticaria—Sorafenib—liver cancer	0.000365	0.00781	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—liver cancer	0.000364	0.00778	CcSEcCtD
Bezafibrate—Abdominal pain—Sorafenib—liver cancer	0.000363	0.00777	CcSEcCtD
Bezafibrate—Purpura—Epirubicin—liver cancer	0.000359	0.00766	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—liver cancer	0.000358	0.00764	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—liver cancer	0.000356	0.00761	CcSEcCtD
Bezafibrate—Clofibrate—CYP2E1—liver cancer	0.00035	0.0553	CrCbGaD
Bezafibrate—Renal failure acute—Doxorubicin—liver cancer	0.000347	0.0074	CcSEcCtD
Bezafibrate—Clofibrate—CYP1A1—liver cancer	0.000345	0.0546	CrCbGaD
Bezafibrate—Migraine—Epirubicin—liver cancer	0.00034	0.00727	CcSEcCtD
Bezafibrate—Hypersensitivity—Sorafenib—liver cancer	0.000339	0.00724	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—liver cancer	0.000332	0.00709	CcSEcCtD
Bezafibrate—Pruritus—Sorafenib—liver cancer	0.000325	0.00695	CcSEcCtD
Bezafibrate—Blood creatinine increased—Epirubicin—liver cancer	0.000324	0.00692	CcSEcCtD
Bezafibrate—Liver function test abnormal—Epirubicin—liver cancer	0.000319	0.00682	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—liver cancer	0.000315	0.00673	CcSEcCtD
Bezafibrate—Diarrhoea—Sorafenib—liver cancer	0.000315	0.00672	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000311	0.00665	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000311	0.00665	CcSEcCtD
Bezafibrate—Gastritis—Epirubicin—liver cancer	0.000306	0.00654	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000305	0.00652	CcSEcCtD
Bezafibrate—Muscular weakness—Epirubicin—liver cancer	0.000305	0.00652	CcSEcCtD
Bezafibrate—Dizziness—Sorafenib—liver cancer	0.000304	0.0065	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—liver cancer	0.0003	0.0064	CcSEcCtD
Bezafibrate—Influenza—Epirubicin—liver cancer	0.000299	0.00638	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—liver cancer	0.000295	0.00631	CcSEcCtD
Bezafibrate—Rash—Sorafenib—liver cancer	0.00029	0.00619	CcSEcCtD
Bezafibrate—Dermatitis—Sorafenib—liver cancer	0.00029	0.00619	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000288	0.00616	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000288	0.00616	CcSEcCtD
Bezafibrate—Headache—Sorafenib—liver cancer	0.000288	0.00615	CcSEcCtD
Bezafibrate—Bronchitis—Epirubicin—liver cancer	0.000287	0.00614	CcSEcCtD
Bezafibrate—Pancytopenia—Epirubicin—liver cancer	0.000284	0.00606	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—liver cancer	0.000283	0.00605	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000282	0.00603	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—liver cancer	0.000282	0.00603	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—liver cancer	0.000276	0.00591	CcSEcCtD
Bezafibrate—Indomethacin—PPARG—liver cancer	0.000276	0.0437	CrCbGaD
Bezafibrate—Nausea—Sorafenib—liver cancer	0.000273	0.00584	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Epirubicin—liver cancer	0.000273	0.00583	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—liver cancer	0.000266	0.00568	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000264	0.00564	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—liver cancer	0.000263	0.00561	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—liver cancer	0.000252	0.00539	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000244	0.00522	CcSEcCtD
Bezafibrate—Pharyngitis—Epirubicin—liver cancer	0.000237	0.00507	CcSEcCtD
Bezafibrate—Urinary tract disorder—Epirubicin—liver cancer	0.000236	0.00505	CcSEcCtD
Bezafibrate—Urethral disorder—Epirubicin—liver cancer	0.000234	0.00501	CcSEcCtD
Bezafibrate—Erythema multiforme—Epirubicin—liver cancer	0.000226	0.00483	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—liver cancer	0.00022	0.00469	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—liver cancer	0.000219	0.00467	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—liver cancer	0.000217	0.00464	CcSEcCtD
Bezafibrate—Alopecia—Epirubicin—liver cancer	0.000211	0.00452	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—liver cancer	0.000209	0.00447	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—liver cancer	0.000208	0.00445	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—liver cancer	0.000205	0.00438	CcSEcCtD
Bezafibrate—Muscle spasms—Epirubicin—liver cancer	0.0002	0.00428	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—liver cancer	0.000196	0.00418	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—liver cancer	0.000193	0.00412	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—liver cancer	0.000192	0.00411	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—liver cancer	0.00019	0.00406	CcSEcCtD
Bezafibrate—Muscle spasms—Doxorubicin—liver cancer	0.000185	0.00396	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—liver cancer	0.000178	0.0038	CcSEcCtD
Bezafibrate—Myalgia—Epirubicin—liver cancer	0.000177	0.00379	CcSEcCtD
Bezafibrate—Infection—Epirubicin—liver cancer	0.000169	0.00361	CcSEcCtD
Bezafibrate—Thrombocytopenia—Epirubicin—liver cancer	0.000166	0.00356	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—liver cancer	0.000164	0.0035	CcSEcCtD
Bezafibrate—Infection—Doxorubicin—liver cancer	0.000156	0.00334	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000155	0.00331	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—liver cancer	0.000154	0.00329	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—liver cancer	0.000154	0.00328	CcSEcCtD
Bezafibrate—Dyspepsia—Epirubicin—liver cancer	0.00015	0.0032	CcSEcCtD
Bezafibrate—Constipation—Epirubicin—liver cancer	0.000145	0.0031	CcSEcCtD
Bezafibrate—Pain—Epirubicin—liver cancer	0.000145	0.0031	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000143	0.00306	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—liver cancer	0.000142	0.00304	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Epirubicin—liver cancer	0.000139	0.00297	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—liver cancer	0.000138	0.00296	CcSEcCtD
Bezafibrate—Urticaria—Epirubicin—liver cancer	0.000135	0.00288	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—liver cancer	0.000134	0.00287	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—liver cancer	0.000134	0.00287	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—liver cancer	0.000134	0.00287	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000129	0.00275	CcSEcCtD
Bezafibrate—Hypersensitivity—Epirubicin—liver cancer	0.000125	0.00268	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—liver cancer	0.000125	0.00267	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—liver cancer	0.000124	0.00266	CcSEcCtD
Bezafibrate—Pruritus—Epirubicin—liver cancer	0.00012	0.00257	CcSEcCtD
Bezafibrate—Diarrhoea—Epirubicin—liver cancer	0.000116	0.00248	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—liver cancer	0.000116	0.00248	CcSEcCtD
Bezafibrate—Dizziness—Epirubicin—liver cancer	0.000112	0.0024	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—liver cancer	0.000111	0.00238	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—liver cancer	0.000108	0.0023	CcSEcCtD
Bezafibrate—Rash—Epirubicin—liver cancer	0.000107	0.00229	CcSEcCtD
Bezafibrate—Dermatitis—Epirubicin—liver cancer	0.000107	0.00229	CcSEcCtD
Bezafibrate—Headache—Epirubicin—liver cancer	0.000106	0.00227	CcSEcCtD
Bezafibrate—Dizziness—Doxorubicin—liver cancer	0.000104	0.00222	CcSEcCtD
Bezafibrate—Indomethacin—ALB—liver cancer	0.000104	0.0164	CrCbGaD
Bezafibrate—Nausea—Epirubicin—liver cancer	0.000101	0.00216	CcSEcCtD
Bezafibrate—Rash—Doxorubicin—liver cancer	9.91e-05	0.00212	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—liver cancer	9.9e-05	0.00212	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—liver cancer	9.85e-05	0.0021	CcSEcCtD
Bezafibrate—Glyburide—ALB—liver cancer	9.39e-05	0.0148	CrCbGaD
Bezafibrate—Nausea—Doxorubicin—liver cancer	9.34e-05	0.002	CcSEcCtD
Bezafibrate—PPARG—Metabolism—HPGDS—liver cancer	2.41e-05	0.000172	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—MTHFR—liver cancer	2.41e-05	0.000172	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTA1—liver cancer	2.4e-05	0.000172	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NAT2—liver cancer	2.37e-05	0.00017	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PPARA—liver cancer	2.36e-05	0.000169	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—IL6—liver cancer	2.36e-05	0.000169	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—liver cancer	2.32e-05	0.000166	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTP1—liver cancer	2.3e-05	0.000164	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—STAT3—liver cancer	2.29e-05	0.000164	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.28e-05	0.000163	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALDOB—liver cancer	2.27e-05	0.000163	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSTM1—liver cancer	2.27e-05	0.000162	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	2.27e-05	0.000162	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—liver cancer	2.26e-05	0.000162	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—SERPINE1—liver cancer	2.26e-05	0.000162	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTP1—liver cancer	2.26e-05	0.000162	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—HMOX1—liver cancer	2.23e-05	0.000159	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.18e-05	0.000156	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—RAF1—liver cancer	2.18e-05	0.000156	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CRABP1—liver cancer	2.17e-05	0.000155	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—PPARA—liver cancer	2.17e-05	0.000155	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.15e-05	0.000154	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP1A1—liver cancer	2.15e-05	0.000154	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PSMA4—liver cancer	2.14e-05	0.000153	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PSMD10—liver cancer	2.14e-05	0.000153	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MAPK14—liver cancer	2.14e-05	0.000153	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TGFB1—liver cancer	2.13e-05	0.000152	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.12e-05	0.000152	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTM1—liver cancer	2.11e-05	0.000151	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ESR1—liver cancer	2.1e-05	0.00015	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GOT2—liver cancer	2.09e-05	0.000149	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	2.08e-05	0.000149	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTM1—liver cancer	2.07e-05	0.000148	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CG—liver cancer	2.02e-05	0.000145	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—MTHFR—liver cancer	2e-05	0.000143	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP1A1—liver cancer	2e-05	0.000143	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2e-05	0.000143	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—liver cancer	1.98e-05	0.000142	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	1.97e-05	0.000141	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—liver cancer	1.97e-05	0.000141	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPARA—liver cancer	1.97e-05	0.000141	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP1A1—liver cancer	1.97e-05	0.000141	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP2E1—liver cancer	1.96e-05	0.00014	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.95e-05	0.00014	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PPARG—liver cancer	1.95e-05	0.00014	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PPARG—liver cancer	1.91e-05	0.000137	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.9e-05	0.000136	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HPGDS—liver cancer	1.89e-05	0.000136	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—liver cancer	1.89e-05	0.000135	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.88e-05	0.000135	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—H2AFX—liver cancer	1.86e-05	0.000133	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—liver cancer	1.85e-05	0.000132	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CPT1B—liver cancer	1.84e-05	0.000132	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GLUL—liver cancer	1.84e-05	0.000132	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYCS—liver cancer	1.84e-05	0.000131	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—MTHFR—liver cancer	1.83e-05	0.000131	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.83e-05	0.000131	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GOT1—liver cancer	1.8e-05	0.000129	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GGT1—liver cancer	1.8e-05	0.000129	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CD—liver cancer	1.78e-05	0.000127	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NR1H4—liver cancer	1.78e-05	0.000127	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.77e-05	0.000126	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ALB—liver cancer	1.75e-05	0.000126	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTA3—liver cancer	1.75e-05	0.000125	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—SERPINE1—liver cancer	1.72e-05	0.000123	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.72e-05	0.000123	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.69e-05	0.000121	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CPT1B—liver cancer	1.69e-05	0.000121	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GLUL—liver cancer	1.69e-05	0.000121	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PSMA4—liver cancer	1.69e-05	0.000121	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PSMD10—liver cancer	1.69e-05	0.000121	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CG—liver cancer	1.68e-05	0.000121	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—liver cancer	1.67e-05	0.00012	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—liver cancer	1.66e-05	0.000119	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PPARA—liver cancer	1.66e-05	0.000119	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—liver cancer	1.64e-05	0.000118	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GOT2—liver cancer	1.64e-05	0.000118	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NR1H4—liver cancer	1.63e-05	0.000117	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPARG—liver cancer	1.63e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—liver cancer	1.62e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTP1—liver cancer	1.62e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.62e-05	0.000116	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	1.61e-05	0.000115	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—liver cancer	1.6e-05	0.000115	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTA3—liver cancer	1.6e-05	0.000115	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTA4—liver cancer	1.6e-05	0.000114	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—HMOX1—liver cancer	1.6e-05	0.000114	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTA2—liver cancer	1.56e-05	0.000111	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CB—liver cancer	1.55e-05	0.000111	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP2E1—liver cancer	1.54e-05	0.000111	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CG—liver cancer	1.54e-05	0.00011	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK14—liver cancer	1.53e-05	0.00011	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TGFB1—liver cancer	1.52e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTA1—liver cancer	1.5e-05	0.000108	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR1—liver cancer	1.5e-05	0.000107	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UGDH—liver cancer	1.5e-05	0.000107	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.5e-05	0.000107	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTM1—liver cancer	1.49e-05	0.000106	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PPARG—liver cancer	1.49e-05	0.000106	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NAT2—liver cancer	1.49e-05	0.000106	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CD—liver cancer	1.48e-05	0.000106	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—liver cancer	1.48e-05	0.000106	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTA4—liver cancer	1.46e-05	0.000105	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—liver cancer	1.46e-05	0.000105	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	1.46e-05	0.000104	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYCS—liver cancer	1.45e-05	0.000103	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.43e-05	0.000102	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—liver cancer	1.43e-05	0.000102	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.43e-05	0.000102	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTA2—liver cancer	1.43e-05	0.000102	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDOB—liver cancer	1.42e-05	0.000102	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—liver cancer	1.42e-05	0.000102	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GGT1—liver cancer	1.42e-05	0.000101	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GOT1—liver cancer	1.42e-05	0.000101	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—liver cancer	1.41e-05	0.000101	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP1A1—liver cancer	1.41e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—EPT1—liver cancer	1.41e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTA1—liver cancer	1.38e-05	9.86e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NAT2—liver cancer	1.36e-05	9.75e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CRABP1—liver cancer	1.36e-05	9.72e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CD—liver cancer	1.35e-05	9.69e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—liver cancer	1.34e-05	9.56e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TAT—liver cancer	1.33e-05	9.55e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—liver cancer	1.31e-05	9.4e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.31e-05	9.37e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDOB—liver cancer	1.31e-05	9.34e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CB—liver cancer	1.29e-05	9.23e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PPARA—liver cancer	1.29e-05	9.22e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—liver cancer	1.27e-05	9.12e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HMOX1—liver cancer	1.26e-05	8.99e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CRABP1—liver cancer	1.25e-05	8.91e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SERPINE1—liver cancer	1.23e-05	8.83e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.22e-05	8.75e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—liver cancer	1.2e-05	8.58e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HPGDS—liver cancer	1.19e-05	8.5e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.18e-05	8.45e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CB—liver cancer	1.18e-05	8.45e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—liver cancer	1.17e-05	8.38e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.16e-05	8.28e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—liver cancer	1.15e-05	8.21e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.12e-05	8.03e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP1A1—liver cancer	1.11e-05	7.94e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CG—liver cancer	1.1e-05	7.9e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—liver cancer	1.09e-05	7.8e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HPGDS—liver cancer	1.09e-05	7.79e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.08e-05	7.75e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.08e-05	7.7e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.06e-05	7.6e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—liver cancer	1.06e-05	7.58e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PSMA4—liver cancer	1.06e-05	7.57e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PSMD10—liver cancer	1.06e-05	7.57e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—liver cancer	1.03e-05	7.4e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GOT2—liver cancer	1.03e-05	7.37e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARA—liver cancer	1.01e-05	7.26e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—liver cancer	9.92e-06	7.1e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.86e-06	7.05e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.73e-06	6.96e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PSMD10—liver cancer	9.7e-06	6.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PSMA4—liver cancer	9.7e-06	6.94e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CD—liver cancer	9.7e-06	6.94e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2E1—liver cancer	9.68e-06	6.93e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—liver cancer	9.58e-06	6.85e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—liver cancer	9.44e-06	6.76e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GOT2—liver cancer	9.44e-06	6.76e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.37e-06	6.71e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.12e-06	6.52e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GLUL—liver cancer	9.07e-06	6.49e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CPT1B—liver cancer	9.07e-06	6.49e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYCS—liver cancer	9.06e-06	6.48e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GOT1—liver cancer	8.89e-06	6.36e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GGT1—liver cancer	8.89e-06	6.36e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2E1—liver cancer	8.87e-06	6.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NR1H4—liver cancer	8.74e-06	6.26e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CG—liver cancer	8.69e-06	6.22e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA3—liver cancer	8.6e-06	6.15e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.59e-06	6.15e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CB—liver cancer	8.46e-06	6.05e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—liver cancer	8.39e-06	6e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYCS—liver cancer	8.3e-06	5.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GOT1—liver cancer	8.15e-06	5.83e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GGT1—liver cancer	8.15e-06	5.83e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—liver cancer	7.98e-06	5.71e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMOX1—liver cancer	7.87e-06	5.63e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—liver cancer	7.87e-06	5.63e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA4—liver cancer	7.86e-06	5.63e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—liver cancer	7.81e-06	5.59e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—liver cancer	7.71e-06	5.52e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA2—liver cancer	7.66e-06	5.48e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CD—liver cancer	7.64e-06	5.47e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—liver cancer	7.56e-06	5.41e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—liver cancer	7.54e-06	5.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA1—liver cancer	7.39e-06	5.29e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—liver cancer	7.34e-06	5.25e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—liver cancer	7.32e-06	5.24e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NAT2—liver cancer	7.31e-06	5.23e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMOX1—liver cancer	7.22e-06	5.17e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—liver cancer	7.19e-06	5.15e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDOB—liver cancer	7.01e-06	5.01e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—liver cancer	6.73e-06	4.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CRABP1—liver cancer	6.69e-06	4.78e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CB—liver cancer	6.66e-06	4.77e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—liver cancer	6.48e-06	4.64e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—liver cancer	6.43e-06	4.6e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP1A1—liver cancer	6.38e-06	4.56e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARA—liver cancer	6.36e-06	4.55e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—liver cancer	5.94e-06	4.25e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—liver cancer	5.88e-06	4.21e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HPGDS—liver cancer	5.84e-06	4.18e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARA—liver cancer	5.83e-06	4.17e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.71e-06	4.09e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CG—liver cancer	5.45e-06	3.9e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—liver cancer	5.42e-06	3.88e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—liver cancer	5.26e-06	3.76e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.24e-06	3.75e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PSMD10—liver cancer	5.21e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PSMA4—liver cancer	5.21e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—liver cancer	5.16e-06	3.69e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GOT2—liver cancer	5.07e-06	3.63e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CG—liver cancer	4.99e-06	3.57e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—liver cancer	4.82e-06	3.45e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CD—liver cancer	4.79e-06	3.43e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2E1—liver cancer	4.76e-06	3.41e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—liver cancer	4.73e-06	3.38e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYCS—liver cancer	4.46e-06	3.19e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CD—liver cancer	4.39e-06	3.14e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GOT1—liver cancer	4.37e-06	3.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GGT1—liver cancer	4.37e-06	3.13e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—liver cancer	4.33e-06	3.1e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—liver cancer	4.21e-06	3.01e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CB—liver cancer	4.17e-06	2.99e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—liver cancer	4.06e-06	2.91e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—liver cancer	3.93e-06	2.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMOX1—liver cancer	3.87e-06	2.77e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CB—liver cancer	3.83e-06	2.74e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—liver cancer	3.61e-06	2.58e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP1A1—liver cancer	3.42e-06	2.45e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—liver cancer	3.32e-06	2.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—liver cancer	3.19e-06	2.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARA—liver cancer	3.13e-06	2.24e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CG—liver cancer	2.68e-06	1.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—liver cancer	2.59e-06	1.85e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—liver cancer	2.54e-06	1.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CD—liver cancer	2.36e-06	1.69e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—liver cancer	2.33e-06	1.67e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—liver cancer	2.33e-06	1.66e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—liver cancer	2.08e-06	1.49e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CB—liver cancer	2.05e-06	1.47e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—liver cancer	1.91e-06	1.36e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—liver cancer	1.25e-06	8.96e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—liver cancer	1.02e-06	7.32e-06	CbGpPWpGaD
